Cellebrite Announces Q1 2024 Results
Ticker: CLBT · Form: 6-K · Filed: May 23, 2024 · CIK: 1854587
| Field | Detail |
|---|---|
| Company | Cellebrite Di Ltd. (CLBT) |
| Form Type | 6-K |
| Filed Date | May 23, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: earnings, foreign-issuer, sec-filing
TL;DR
Cellebrite dropped its Q1 2024 earnings report today.
AI Summary
Cellebrite DI Ltd. announced its first-quarter 2024 results on May 23, 2024. The company is a foreign private issuer based in Israel and filed a Form 6-K to report this information. The press release detailing these results is furnished as Exhibit 99.1.
Why It Matters
This filing provides investors with the latest financial performance data for Cellebrite DI Ltd., crucial for assessing the company's current health and future prospects.
Risk Assessment
Risk Level: low — This is a routine earnings report filing, not indicating any immediate operational or financial distress.
Key Players & Entities
- Cellebrite DI Ltd. (company) — The company filing the report.
- May 23, 2024 (date) — Date of the press release and filing.
- 94 Shlomo Shmelzer Road Petah Tikva 4970602, Israel (address) — Principal executive office of Cellebrite DI Ltd.
FAQ
What type of report is Cellebrite DI Ltd. filing?
Cellebrite DI Ltd. is filing a Form 6-K, which is a Report of Foreign Private Issuer.
When did Cellebrite DI Ltd. announce its first-quarter 2024 results?
Cellebrite DI Ltd. announced its first-quarter 2024 results on May 23, 2024.
Where is Cellebrite DI Ltd. headquartered?
Cellebrite DI Ltd.'s principal executive office is located at 94 Shlomo Shmelzer Road, Petah Tikva 4970602, Israel.
What is the SEC file number for Cellebrite DI Ltd.?
The SEC file number for Cellebrite DI Ltd. is 001-40772.
What exhibit contains the press release with the Q1 2024 results?
The press release titled 'Cellebrite Announces First-Quarter 2024 Results' is furnished as Exhibit 99.1.
Filing Stats: 236 words · 1 min read · ~1 pages · Grade level 10.3 · Accepted 2024-05-23 07:15:09
Filing Documents
- ea0206613-6k_cellebrite.htm (6-K) — 12KB
- ea020661301ex99-1_cellebrite.htm (EX-99.1) — 168KB
- ex99-1_001.jpg (GRAPHIC) — 3KB
- 0001213900-24-046080.txt ( ) — 185KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Cellebrite DI Ltd. Date: May 23 , 2024 By: /s/ Dana Gerner Dana Gerner Chief Financial Officer 3